EU/3/18/2042

Table of contents

About

On 31 July 2018, orphan designation (EU/3/18/2042) was granted by the European Commission to MeiraGTx UK II Limited, United Kingdom, for adenovirus associated viral vector serotype 2/8 containing the human CNGA3 gene for the treatment of achromatopsia.

The sponsorship was transferred to MeiraGTx B.V., The Netherlands in May 2019.

Key facts

Active substance
Adenovirus associated viral vector serotype 2/8 containing the human CNGA3 gene
Disease / condition
Treatment of achromatopsia
Date of first decision
31/07/2018
Outcome
Positive
EU designation number
EU/3/18/2042

Sponsor's contact details

MeiraGTx B.V.
Robert Boyleweg 4
2333 CG Leiden
Zuid-Holland
The Netherlands
Tel. +31 (0) 6480 67303
E-mail: info@meiragtx.com

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;

How useful was this page?

Add your rating